# Invoke Bio

Source: https://onco.cc/companies/invoke-bio/  
OnCo record `invoke-bio` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Invoke Bio designs personalised neoantigen vaccines in whatever form suits the patient, peptide, DNA or mRNA, using a prediction engine it says picks tumour targets with three times the accuracy of industry baselines.

## Summary

Invoke Bio's immunogenicity prediction engine identifies tumour neoantigens for personalised vaccines and is modality-agnostic, supporting peptide, DNA and mRNA formats. Future of Cancer Care Today lists it as patient-orderable.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: United States (city not published)
- Type: biotech
- Website: https://invoke.bio/

## Sources

- Official website: https://invoke.bio/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- technologies: [Personalised neoantigen (mRNA) vaccines](https://onco.cc/technologies/neoantigen-mrna-vaccine/)

---
JSON: https://onco.cc/api/v1/entities/invoke-bio.json